Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).

Clinical trial NCT05052229 · UNKNOWN

Trial details

NCT number: NCT05052229
Sponsor: Dr. Denis O'Donnell
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2022-04-21
Primary completion: 2024-12-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.